vs
GE医疗（DHC）与Ecovyst Inc.（ECVT）财务数据对比。点击上方公司名可切换其他公司
GE医疗的季度营收约是Ecovyst Inc.的1.9倍（$379.6M vs $199.4M），Ecovyst Inc.同比增速更快（34.0% vs -0.0%），Ecovyst Inc.自由现金流更多（$22.9M vs $-166.4M），过去两年Ecovyst Inc.的营收复合增速更高（18.7% vs 1.2%）
GE医疗是一家总部位于美国伊利诺伊州芝加哥市的医疗科技企业，业务涵盖四大板块：医疗影像设备，包括分子成像、CT、核磁共振、妇科健康筛查及X光系统；超声设备；患者护理解决方案，聚焦远程患者监测、麻醉呼吸护理、心脏诊断及婴幼儿护理；此外还涉及医药相关领域，是全球医疗行业的知名企业。
Ecovyst Inc.是一家全球可持续特种材料供应商，主营高性能催化剂与功能性添加剂的研发、生产，产品服务覆盖工业制造、消费品、环保等核心领域，助力全球客户提升运营效率、降低碳排放。
DHC vs ECVT — 直观对比
营收规模更大
DHC
是对方的1.9倍
$199.4M
营收增速更快
ECVT
高出34.0%
-0.0%
自由现金流更多
ECVT
多$189.4M
$-166.4M
两年增速更快
ECVT
近两年复合增速
1.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $379.6M | $199.4M |
| 净利润 | $-21.2M | — |
| 毛利率 | — | 23.4% |
| 营业利润率 | -12.6% | 10.9% |
| 净利率 | -5.6% | — |
| 营收同比 | -0.0% | 34.0% |
| 净利润同比 | 75.7% | — |
| 每股收益（稀释后） | $-0.09 | $0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DHCECVT
| Q4 25 | $379.6M | $199.4M | ||
| Q3 25 | $388.7M | $204.9M | ||
| Q2 25 | $382.7M | $176.1M | ||
| Q1 25 | $386.9M | $143.1M | ||
| Q4 24 | $379.6M | $148.9M | ||
| Q3 24 | $373.6M | $153.9M | ||
| Q2 24 | $371.4M | $154.0M | ||
| Q1 24 | $370.8M | $141.6M |
净利润DHCECVT
| Q4 25 | $-21.2M | — | ||
| Q3 25 | $-164.0M | $-79.3M | ||
| Q2 25 | $-91.6M | $6.0M | ||
| Q1 25 | $-9.0M | $-3.6M | ||
| Q4 24 | $-87.4M | — | ||
| Q3 24 | $-98.7M | $14.3M | ||
| Q2 24 | $-97.9M | $8.3M | ||
| Q1 24 | $-86.3M | $1.2M |
毛利率DHCECVT
| Q4 25 | — | 23.4% | ||
| Q3 25 | — | 25.4% | ||
| Q2 25 | — | 22.8% | ||
| Q1 25 | — | 13.3% | ||
| Q4 24 | — | 28.9% | ||
| Q3 24 | — | 29.3% | ||
| Q2 24 | — | 27.3% | ||
| Q1 24 | — | 23.5% |
营业利润率DHCECVT
| Q4 25 | -12.6% | 10.9% | ||
| Q3 25 | -43.4% | 13.8% | ||
| Q2 25 | -24.5% | 9.0% | ||
| Q1 25 | -2.7% | -0.7% | ||
| Q4 24 | -26.1% | 15.1% | ||
| Q3 24 | -26.5% | 17.9% | ||
| Q2 24 | -23.0% | 14.1% | ||
| Q1 24 | -23.7% | 9.5% |
净利率DHCECVT
| Q4 25 | -5.6% | — | ||
| Q3 25 | -42.2% | -38.7% | ||
| Q2 25 | -23.9% | 3.4% | ||
| Q1 25 | -2.3% | -2.5% | ||
| Q4 24 | -23.0% | — | ||
| Q3 24 | -26.4% | 9.3% | ||
| Q2 24 | -26.3% | 5.4% | ||
| Q1 24 | -23.3% | 0.9% |
每股收益（稀释后）DHCECVT
| Q4 25 | $-0.09 | $0.06 | ||
| Q3 25 | $-0.68 | $-0.69 | ||
| Q2 25 | $-0.38 | $0.05 | ||
| Q1 25 | $-0.04 | $-0.03 | ||
| Q4 24 | $-0.37 | $-0.26 | ||
| Q3 24 | $-0.41 | $0.12 | ||
| Q2 24 | $-0.41 | $0.07 | ||
| Q1 24 | $-0.36 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $105.4M | $197.2M |
| 总债务越低越好 | $2.4B | $392.6M |
| 股东权益账面价值 | $1.7B | $603.4M |
| 总资产 | $4.4B | $1.3B |
| 负债/权益比越低杠杆越低 | 1.47× | 0.65× |
8季度趋势，按日历期对齐
现金及短期投资DHCECVT
| Q4 25 | $105.4M | $197.2M | ||
| Q3 25 | $201.4M | $82.0M | ||
| Q2 25 | $141.8M | $69.6M | ||
| Q1 25 | $302.6M | $127.5M | ||
| Q4 24 | $144.6M | $131.4M | ||
| Q3 24 | $256.5M | $123.5M | ||
| Q2 24 | $265.6M | $83.3M | ||
| Q1 24 | $207.1M | $103.1M |
总债务DHCECVT
| Q4 25 | $2.4B | $392.6M | ||
| Q3 25 | — | $854.8M | ||
| Q2 25 | — | $856.6M | ||
| Q1 25 | — | $859.0M | ||
| Q4 24 | $3.1B | $860.8M | ||
| Q3 24 | — | $862.7M | ||
| Q2 24 | — | $862.4M | ||
| Q1 24 | — | $866.2M |
股东权益DHCECVT
| Q4 25 | $1.7B | $603.4M | ||
| Q3 25 | $1.7B | $607.9M | ||
| Q2 25 | $1.9B | $692.4M | ||
| Q1 25 | $1.9B | $698.7M | ||
| Q4 24 | $2.0B | $700.5M | ||
| Q3 24 | $2.0B | $729.4M | ||
| Q2 24 | $2.1B | $717.3M | ||
| Q1 24 | $2.2B | $711.4M |
总资产DHCECVT
| Q4 25 | $4.4B | $1.3B | ||
| Q3 25 | $4.7B | $1.7B | ||
| Q2 25 | $4.8B | $1.8B | ||
| Q1 25 | $5.0B | $1.8B | ||
| Q4 24 | $5.1B | $1.8B | ||
| Q3 24 | $5.3B | $1.8B | ||
| Q2 24 | $5.3B | $1.8B | ||
| Q1 24 | $5.3B | $1.8B |
负债/权益比DHCECVT
| Q4 25 | 1.47× | 0.65× | ||
| Q3 25 | — | 1.41× | ||
| Q2 25 | — | 1.24× | ||
| Q1 25 | — | 1.23× | ||
| Q4 24 | 1.56× | 1.23× | ||
| Q3 24 | — | 1.18× | ||
| Q2 24 | — | 1.20× | ||
| Q1 24 | — | 1.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-19.6M | $41.8M |
| 自由现金流经营现金流 - 资本支出 | $-166.4M | $22.9M |
| 自由现金流率自由现金流/营收 | -43.8% | 11.5% |
| 资本支出强度资本支出/营收 | 38.7% | 9.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-280.3M | $69.9M |
8季度趋势，按日历期对齐
经营现金流DHCECVT
| Q4 25 | $-19.6M | $41.8M | ||
| Q3 25 | $-49.3M | $55.3M | ||
| Q2 25 | $53.0M | $33.0M | ||
| Q1 25 | $-3.2M | $10.3M | ||
| Q4 24 | $112.2M | $43.5M | ||
| Q3 24 | $21.1M | $59.9M | ||
| Q2 24 | $44.3M | $10.0M | ||
| Q1 24 | $28.6M | $36.5M |
自由现金流DHCECVT
| Q4 25 | $-166.4M | $22.9M | ||
| Q3 25 | $-89.8M | $53.2M | ||
| Q2 25 | $18.8M | $7.8M | ||
| Q1 25 | $-42.9M | $-14.0M | ||
| Q4 24 | $-89.5M | $30.9M | ||
| Q3 24 | $-26.1M | $53.6M | ||
| Q2 24 | $3.3M | $-9.3M | ||
| Q1 24 | $-18.1M | $19.1M |
自由现金流率DHCECVT
| Q4 25 | -43.8% | 11.5% | ||
| Q3 25 | -23.1% | 26.0% | ||
| Q2 25 | 4.9% | 4.4% | ||
| Q1 25 | -11.1% | -9.8% | ||
| Q4 24 | -23.6% | 20.7% | ||
| Q3 24 | -7.0% | 34.9% | ||
| Q2 24 | 0.9% | -6.1% | ||
| Q1 24 | -4.9% | 13.5% |
资本支出强度DHCECVT
| Q4 25 | 38.7% | 9.4% | ||
| Q3 25 | 10.4% | 1.0% | ||
| Q2 25 | 8.9% | 14.4% | ||
| Q1 25 | 10.2% | 16.9% | ||
| Q4 24 | 53.1% | 8.5% | ||
| Q3 24 | 12.6% | 4.1% | ||
| Q2 24 | 11.0% | 12.5% | ||
| Q1 24 | 12.6% | 12.3% |
现金转化率DHCECVT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 5.52× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 4.21× | ||
| Q2 24 | — | 1.20× | ||
| Q1 24 | — | 29.90× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DHC
| Senior Housing Operating Portfolio Segment | $323.4M | 85% |
| Rental Income | $56.2M | 15% |
ECVT
| Industrial Mining Automotive | $101.3M | 51% |
| Regeneration And Treatment Services | $90.0M | 45% |
| Other | $8.1M | 4% |
